Details for New Drug Application (NDA): 050730
✉ Email this page to a colleague
The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
Summary for 050730
Tradename: | ZITHROMAX |
Applicant: | Pfizer |
Ingredient: | azithromycin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050730
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 12, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 050730
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | ZITHROMAX | azithromycin | TABLET;ORAL | 050730-001 | Jun 12, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription